Search results
Moderna Beats Quarterly Estimates as Cost-Cutting Pares Losses
Bloomberg· 1 day agoModerna Inc. reported a narrower first-quarter loss than Wall Street had expected, as the biotech...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 1 day agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna Inc (MRNA) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...
GuruFocus.com via Yahoo Finance· 5 hours agoRelease Date: May 02, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Moderna Inc (NASDAQ:MRNA) reported ...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 17 hours agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its ...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 21 hours agoMuch of Moderna’s focus is on nabbing FDA approval for a respiratory syncytial virus vaccine, a...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 18 hours agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
Moderna makes several cost-cutting moves, leans into AI - Boston Business Journal
The Business Journals· 22 hours agoAs Moderna Inc. works toward expanding its approved products beyond its Covid-19 vaccine, the...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 14 hours agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company’s first quarter ...
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
Zacks via Yahoo Finance· 7 days agoModerna (MRNA) closed the most recent trading day at $107.97, moving +1.69% from the previous...
Moderna Inc (MRNA) Q1 2024 Earnings: Significant Revenue Decline
Guru Focus· 1 day agoOn May 2, 2024, Moderna Inc (MRNA, Financial) released its 8-K filing, disclosing a challenging first quarter with total revenues of $167 million, a stark decline from $1.9 ...